2016
DOI: 10.1111/1346-8138.13535
|View full text |Cite
|
Sign up to set email alerts
|

Bullous eosinophilic annular erythema

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
9
1

Year Published

2017
2017
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(12 citation statements)
references
References 5 publications
(2 reference statements)
2
9
1
Order By: Relevance
“…The male:female ratio of EAE was 3 : 7 in our cases and 13 : 15 in previous reports; there is a slight predominance in females . The reason is yet to be elucidated, but three EAE female cases had a history of autoimmune disorders in our study.…”
Section: Discussioncontrasting
confidence: 50%
See 1 more Smart Citation
“…The male:female ratio of EAE was 3 : 7 in our cases and 13 : 15 in previous reports; there is a slight predominance in females . The reason is yet to be elucidated, but three EAE female cases had a history of autoimmune disorders in our study.…”
Section: Discussioncontrasting
confidence: 50%
“…As stated in the first report of eosinophilic annular erythema (EAE), the entity of EAE was proposed to describe annular skin lesions associated with tissue eosinophilia . To date, 25 cases of EAE have been reported in the English literature . EAE is characterized by the appearance of persistent annular or figurate lesions, a chronic course with recurrent relapse and recalcitrance to various treatments .…”
Section: Introductionmentioning
confidence: 99%
“…Eosinophilic annular erythema presents with annular, figurate urticarial edematous plaques primarily affecting the trunk and proximal limbs. A bullous variant has also been reported [1], as with our patient. We postulate that this clinical variant may result from an intense inflammatory infiltrate and dermal edema.…”
Section: Case Discussionsupporting
confidence: 83%
“…Reported treatment for this condition includes corticosteroids [1][2][3], antimalarial drugs [3,5], dapsone, indomethacin [4], cyclosporine [6] and Dermatology Online Journal || Photo Vignette dupilumab [7]. Our patient responded well to potent topical corticosteroids.…”
Section: Case Discussionmentioning
confidence: 73%
See 1 more Smart Citation